Barely Significant
← all phrases

“marginally non-significant”

1,494 sentences · 1,494 papers · 1,908 search hits before verification

In the literature

marginally non-significantp < 0.051.0× alpha
Contrary to expectations that synapsids would follow a consistently optimal path toward a more therian morphology, our results based on reconstructed landscapes for major nodes show statistically significant fluctuations in optimality across the major synapsid groups (with marginally non-significant effects of centroid size; RPPP ANOVA, p < 0.05, see S7 Table ).
marginally non-significantp = 0.051.0× alpha
Results Immune Priming and Serratia Marcescens Infections For Experiment 1 ( Figure 1A, B ), the minimal model indicated a marginally non-significant interaction between aphid genotype, pre-exposure, and infection treatment upon second challenge (p = 0.05), which is reflected by the somewhat different responses of the two aphid genotypes (5A0, LSR1) to pre-exposure and subsequent live bacterial challenge ( Figure 1A,B ).
marginally non-significantp = 0.0501.0× alpha
Results ApEn and PE values in different anesthesia-awakening stages For ApEn values, ANOVA analysis ( Table 1 ) revealed significant main effects for the factors “stage” ( F 2,24 = 25.127; p = 0.000; partial η 2 = 0.677) and “sex” ( F 1,12 = 5.033; p = 0.045; partial η 2 = 0.295) but marginally non-significant effect for the factor “brain area” ( F 5,60 = 2.373; p = 0.050; partial η 2 = 0.165), but no significant interaction between factors was observed.
marginally non-significantp -value = 0.051.0× alpha
The change of the binding potential in the left putamen ( r = 0.64, p = 0.01) had a marginally non-significant stronger ( z = 1.57, p -value = 0.05) correlation with externalizing symptoms than the change of the binding potential of the right putamen ( r = 0.17, p = 0.58).
marginally non-significantp = 0.051.0× alpha
The variables examined were: aerobic capacity for exercise, lung function, anxiety and depression, with non-significant improvement for the MRC Dyspnea scale, marginally non-significant improvement regarding 6MWT ( p = 0.05) and significant improvement for FEV1 ( p < 0.05).
marginally non-significantp = 0.051.0× alpha
Further, when patients were dichotomized based on the disease control rate (“DCR”), a significantly longer OS was exhibited in the disease control compared to no-disease control group according to PERCIST (p = 0.01), PERCIMT (p = 0.01) and iPERCIST (p = 0.01), while a similar, marginally non-significant trend was also observed after application of EORTC (p = 0.05).
marginally non-significantp = 0.051.0× alpha
While subgroup analysis revealed a marginally non-significant effect in the subacute phase (MD = 0.88; p = 0.05) and a non-significant effect in the chronic phase, the test for subgroup differences was not significant ( p = 0.91), suggesting comparable benefits regardless of recovery stage.